Exact Sciences (EXAS) Beats Q3 EPS by 6c, FY Revenue Guidance Tops Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. QQQ
8. LDOS
9. HUM
10. KTOS

Go back to Exact Sciences (EXAS) Beats Q3 EPS by 6c, FY Revenue Guidance Tops Views

Exact Sciences Completes 68,000 Cologuard Tests During the Third Quarter

October 26, 2016 6:00 AM EDT

MADISON, Wis., Oct. 26, 2016 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenues of $28.1 million during the third quarter ended Sept. 30, 2016, an increase of 123 percent from $12.6 million in the third quarter of 2015.  The company completed approximately 68,000 Cologuard tests during the quarter, an increase of approximately 100 percent from the same quarter of 2015. Since the launch of Cologuard and through the end of the third quarter of 2016, nearly 50,000 providers have ordered the test.

"Our sales and marketing... More